EGCG Inhibits Tumor Growth in Melanoma by Targeting JAK-STAT Signaling and Its Downstream PD-L1/PD-L2-PD1 Axis in Tumors and Enhancing Cytotoxic T-Cell ResponsesDinoop Ravindran Menon, Mayumi Fujita|Pharmaceuticals|2021Cited by 88